SOPHiA GENETICS President and CEO Ross Muken discusses the use of AI and technology in diagnosing and treating patients, ...
Every person's DNA tells a unique story. To unlock the full potential of genetic research, scientists need tools that reflect ...
Deep learning approaches have transformed how scientists predict the activity and function of DNA sequences in the genome. A ...
Rare DNA changes are most strongly linked to cognition in early childhood, but the link fades as children age, while common ...
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
Premas Life Sciences and Uncoded participated in GENE-SIGHT 2026, where experts discussed genetics-enabled glaucoma care, precision medicine, early diagnosis, clinical collaboration and policy ...
Genetics influences longevity by providing inherited characteristics related to health, but daily habits are also essential ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces the full commercial launch of ...
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers.
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at 4:30 pm ET on Thursday, July 30, ...
Dr Sofia Nunes, consultant clinical geneticist, Mater Misericordiae University Hospital, Dublin ...